Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OM MUC 1

Next Previous
Search
Drug Profile

OM MUC 1

Alternative Names: Oxidised-mannan MUC1 vaccine

Latest Information Update: 05 Sep 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Austin Research Institute
  • Class Cancer vaccines; Dendritic cell vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 05 Sep 2018 Discontinued - Phase-I/II for Breast cancer (Prevention) in Australia (Parenteral)
  • 05 Sep 2018 Discontinued - Phase-II/III for Breast cancer (Early-stage disease, Prevention, Second-line therapy or greater, Adjuvant therapy) in Greece (Parenteral)
  • 10 Oct 2015 Efficacy, immunogenicity and adverse events data from the phase IIb/III IFCM-9 trial in Breast cancer (Adjuvant therapy, Early-stage disease, Second-line therapy or greater, Prevention) released by Ascend Biopharmaceuticals (3151181; ISRCTN71711835)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top